Jubilant Life Sciences Limited reported unaudited standalone and consolidated earnings results for the third quarter and nine months ended December 31, 2017. For the quarter, on consolidated basis the company reported total revenue from operations of INR 20,677.6 million compared to INR 14,916.4 million a year ago. Profit before exceptional items and tax was INR 2,611.8 million compared to INR 1,661.0 million a year ago. Profit before tax was INR 2,611.8 million compared to INR 1,661.0 million a year ago. Net profit for the period was INR 2,128.4 million compared to INR 1,181.1 million a year ago. Net profit attributable to owners of the company was INR 2,125.4 million compared to INR 1,194.0 million a year ago. Earnings of INR 13.64 per basic and diluted share not annualized compared to INR 7.66 per basic and diluted share not annualized a year ago. EBITDA from operations was INR 4,310 million compared to INR 3,370 million a year ago. Reported EBITDA was INR 4,200 million compared to INR 3,370 million a year ago. Net Debt reduction was INR 1,590 million after incurring capex of INR 700 million.

For the period, on consolidated basis the company reported total revenue from operations of INR 53,058.5 million compared to INR 43,649.0 million a year ago. Profit before exceptional items and tax was INR 6,325.2 million compared to INR 5,775.4 million a year ago. Profit before tax was INR 6,325.2 million compared to INR 5,775.4 million a year ago. Net profit for the period was INR 4,820.0 million compared to INR 4,255.9 million a year ago. Net profit attributable to owners of the company was INR 4,879.4 million compared to INR 4,255.2 million a year ago. Earnings of INR 31.31 per basic and diluted share not annualized compared to INR 27.28 per diluted share not annualized a year ago. EBITDA from operations was INR 11,070 million compared to INR 10,550 million a year ago. Reported EBITDA was INR 10,780 million compared to INR 10,550 million a year ago. Net Debt reduction of INR 1,430 million after Capital Expenditure of INR 2,560 million and Triad acquisition. Normalized profit after tax was INR 5,100 million or INR 32.77 per share compared to INR 4,260 million or INR 27.30 per share a year ago.

For the quarter, on standalone basis the company reported total revenue from operations of INR 9,338.3 million compared to INR 6,380.1 million a year ago. Profit before exceptional items and tax was INR 1,432.3 million compared to INR 170.0 million a year ago. Profit before tax was INR 1,432.3 million compared to INR 170.0 million a year ago. Net profit for the period was INR 978.8 million compared to INR 82.6 million a year ago. Earnings of INR 6.15 per basic and diluted share not annualized compared to INR 0.52 per basic and diluted share not annualized a year ago.

For the period, on standalone basis the company reported total revenue from operations of INR 23,785.8 million compared to INR 18,630.5 million a year ago. Profit before exceptional items and tax was INR 2,489.1 million compared to INR 841.8 million a year ago. Profit before tax was INR 2,489.1 million compared to INR 841.8 million a year ago. Net profit for the period was INR 1,770.5 million compared to INR 533.6 million a year ago. Earnings of INR 11.12 per basic and diluted share not annualized compared to INR 3.35 per basic and diluted share not annualized a year ago.

For the fiscal year 2018, The company expects capital expenditure to be around INR 4,000 million. The company also expects its tax rate for the year around 25%.